+关注
京北风
暂无个人介绍
IP属地:北京
24
关注
3
粉丝
0
主题
0
勋章
主贴
热门
京北风
2021-04-09
$海湾资源(GURE)$
持仓4000股,怎么不显示,无法操作呀
京北风
2020-06-05
这是过山车吗?跌停、涨停,再跌停,在涨停,。。。
京北风
2020-03-09
$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了
京北风
2019-07-18
$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空
京北风
2019-07-18
$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。
京北风
2019-07-18
$Safe-T Group Ltd.(SFET)$先最多,高位在空
京北风
2019-06-03
$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?
京北风
2019-05-31
$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注
京北风
2019-05-29
今天继续有利好
$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯
+148.17%
14.220
SOLITON INC (SOLY.US)
新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。
今天继续有利好
京北风
2019-05-29
$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯
+148.17%
14.220
SOLITON INC (SOLY.US)
新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。
京北风
2019-05-23
$Obalon Therapeutics Inc(OBLN)$ 开牌就暴跌呀
京北风
2019-05-02
$Hemispherx Biopharma Inc(HEB)$ 这股每天盘前诱多,套进多少人呀
京北风
2019-04-29
$Innovate Biopharmaceuticals Inc.(INNT)$ 创新生物制药股份有限公司(INNT)上涨45%,至2.76美元。 这家临床阶段生物技术公司周一表示,醋酸拉拉唑肽是第一种具有新机制的药物,其作用机制可用于证实非酒精性脂肪性肝炎(NASH)、生物标志物和终点的改善。该公司表示,醋酸拉拉嗪肽是一种新的药物,它是以肠限制肽为基础,将肠上皮屏障和肠-肝轴重新命名。 创新说,活检证实的纳什模型的关键图线发现将在消化疾病周会议的分析师会议上提出,并提交给美国肝病研究协会的肝脏会议。 这股今天有利好,走得这么磨叽,有点危呀,再看看吧
京北风
2019-04-29
$Innovate Biopharmaceuticals Inc.(INNT)$ 上车了就耐心持有,开盘再看
京北风
2019-04-29
$Innovate Biopharmaceuticals Inc.(INNT)$ 为什么盘前买入成交,持仓不显示呢?
京北风
2019-04-24
$亚洲杂货(08413)$ 这破股总这么低价位,不会停牌破产吧
京北风
2019-04-19
$Precipio, Inc.(PRPO)$ Preciio公司股份(PRPO)在周二的市场上涨,此前一天,该公司表示,将安排股东电话,审查为重新遵守纳斯达克每股1美元规则而采取的行动,以及该公司继续提高股价的计划。 下午3点49分。ET,专业癌症诊断公司的股票上涨了20.73%,以每股48美分的价格交易。成交量超过8,870万股,远高于65天平均成交量约630万股. Preciio表示,纳斯达克将其合规听证会定于5月2日举行.5月6日的股东电话会议将在该公司完成必要的行动后进行,这些行动旨在重新遵守纳斯达克上市要求。该交易所的股票必须有一个最低的1.00美元的出价,普雷西奥说。
京北风
2018-08-13
$Aytu BioScience, Inc.(AYTU)$今合股了,20股合1股,也不见涨呀
京北风
2018-07-31
$亚洲杂货(08413)$被骗进来巨亏,好在还在账上。福亿证券更缺德,把被骗深套的全给强平了,难友们欲哭无泪,预告无门,那是真惨呀!
京北风
2018-06-15
$方舟生物医药(ABIO)$ 开盘拉高后跳水,诱多呀
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3478140728481399","uuid":"3478140728481399","gmtCreate":1515551867313,"gmtModify":1515551867313,"name":"京北风","pinyin":"jbfjingbeifeng","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":24,"tweetSize":21,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.13","exceedPercentage":"60.72%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.79%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":348750559,"gmtCreate":1617966706971,"gmtModify":1617966706971,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GURE\">$海湾资源(GURE)$</a>持仓4000股,怎么不显示,无法操作呀","listText":"<a href=\"https://laohu8.com/S/GURE\">$海湾资源(GURE)$</a>持仓4000股,怎么不显示,无法操作呀","text":"$海湾资源(GURE)$持仓4000股,怎么不显示,无法操作呀","images":[{"img":"https://static.tigerbbs.com/ff45161b606547954fd2876432f718a6","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/348750559","isVote":1,"tweetType":1,"viewCount":2810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":958719449,"gmtCreate":1591365437981,"gmtModify":1704195558630,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"这是过山车吗?跌停、涨停,再跌停,在涨停,。。。","listText":"这是过山车吗?跌停、涨停,再跌停,在涨停,。。。","text":"这是过山车吗?跌停、涨停,再跌停,在涨停,。。。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/958719449","isVote":1,"tweetType":1,"viewCount":1186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":981217668,"gmtCreate":1583761156054,"gmtModify":1704350687354,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了","listText":"$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了","text":"$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/981217668","isVote":1,"tweetType":1,"viewCount":2402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":999432023,"gmtCreate":1563449785962,"gmtModify":1704705470343,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空","listText":"$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空","text":"$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空","images":[{"img":"https://static.tigerbbs.com/ebb3b6651e839cb360c74443aef2dc69"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/999432023","isVote":1,"tweetType":1,"viewCount":1618,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":999431035,"gmtCreate":1563448379627,"gmtModify":1704705466677,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。","listText":"$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。","text":"$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/999431035","isVote":1,"tweetType":1,"viewCount":2461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":999498730,"gmtCreate":1563443367720,"gmtModify":1704705456575,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Safe-T Group Ltd.(SFET)$先最多,高位在空","listText":"$Safe-T Group Ltd.(SFET)$先最多,高位在空","text":"$Safe-T Group Ltd.(SFET)$先最多,高位在空","images":[{"img":"https://static.tigerbbs.com/14e0898b30b721f21d10c17e189f69f8"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/999498730","isVote":1,"tweetType":1,"viewCount":1062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":902143734,"gmtCreate":1559565610728,"gmtModify":1704698476201,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?","listText":"$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?","text":"$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/902143734","isVote":1,"tweetType":1,"viewCount":1115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":902963026,"gmtCreate":1559305500065,"gmtModify":1704698177750,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注","listText":"$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注","text":"$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/902963026","isVote":1,"tweetType":1,"viewCount":1102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":906433947,"gmtCreate":1559136165189,"gmtModify":1704697741892,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"title":"今天继续有利好","htmlText":"$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","listText":"$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","text":"$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 +148.17% 14.220 SOLITON INC (SOLY.US) 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/906433947","isVote":1,"tweetType":1,"viewCount":1529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":906439220,"gmtCreate":1559136035760,"gmtModify":1704697741548,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","listText":"$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","text":"$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 +148.17% 14.220 SOLITON INC (SOLY.US) 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/906439220","isVote":1,"tweetType":1,"viewCount":1271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":906315261,"gmtCreate":1558616498653,"gmtModify":1704696993633,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Obalon Therapeutics Inc(OBLN)$ 开牌就暴跌呀","listText":"$Obalon Therapeutics Inc(OBLN)$ 开牌就暴跌呀","text":"$Obalon Therapeutics Inc(OBLN)$ 开牌就暴跌呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/906315261","isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":903912852,"gmtCreate":1556797891476,"gmtModify":1704801169213,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Hemispherx Biopharma Inc(HEB)$ 这股每天盘前诱多,套进多少人呀","listText":"$Hemispherx Biopharma Inc(HEB)$ 这股每天盘前诱多,套进多少人呀","text":"$Hemispherx Biopharma Inc(HEB)$ 这股每天盘前诱多,套进多少人呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/903912852","isVote":1,"tweetType":1,"viewCount":1062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909524070,"gmtCreate":1556546999590,"gmtModify":1704800705123,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 创新生物制药股份有限公司(INNT)上涨45%,至2.76美元。 这家临床阶段生物技术公司周一表示,醋酸拉拉唑肽是第一种具有新机制的药物,其作用机制可用于证实非酒精性脂肪性肝炎(NASH)、生物标志物和终点的改善。该公司表示,醋酸拉拉嗪肽是一种新的药物,它是以肠限制肽为基础,将肠上皮屏障和肠-肝轴重新命名。 创新说,活检证实的纳什模型的关键图线发现将在消化疾病周会议的分析师会议上提出,并提交给美国肝病研究协会的肝脏会议。 这股今天有利好,走得这么磨叽,有点危呀,再看看吧","listText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 创新生物制药股份有限公司(INNT)上涨45%,至2.76美元。 这家临床阶段生物技术公司周一表示,醋酸拉拉唑肽是第一种具有新机制的药物,其作用机制可用于证实非酒精性脂肪性肝炎(NASH)、生物标志物和终点的改善。该公司表示,醋酸拉拉嗪肽是一种新的药物,它是以肠限制肽为基础,将肠上皮屏障和肠-肝轴重新命名。 创新说,活检证实的纳什模型的关键图线发现将在消化疾病周会议的分析师会议上提出,并提交给美国肝病研究协会的肝脏会议。 这股今天有利好,走得这么磨叽,有点危呀,再看看吧","text":"$Innovate Biopharmaceuticals Inc.(INNT)$ 创新生物制药股份有限公司(INNT)上涨45%,至2.76美元。 这家临床阶段生物技术公司周一表示,醋酸拉拉唑肽是第一种具有新机制的药物,其作用机制可用于证实非酒精性脂肪性肝炎(NASH)、生物标志物和终点的改善。该公司表示,醋酸拉拉嗪肽是一种新的药物,它是以肠限制肽为基础,将肠上皮屏障和肠-肝轴重新命名。 创新说,活检证实的纳什模型的关键图线发现将在消化疾病周会议的分析师会议上提出,并提交给美国肝病研究协会的肝脏会议。 这股今天有利好,走得这么磨叽,有点危呀,再看看吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/909524070","isVote":1,"tweetType":1,"viewCount":1131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909560768,"gmtCreate":1556543771954,"gmtModify":1704800687867,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 上车了就耐心持有,开盘再看","listText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 上车了就耐心持有,开盘再看","text":"$Innovate Biopharmaceuticals Inc.(INNT)$ 上车了就耐心持有,开盘再看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/909560768","isVote":1,"tweetType":1,"viewCount":1014,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909587065,"gmtCreate":1556543096157,"gmtModify":1704800685794,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 为什么盘前买入成交,持仓不显示呢?","listText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 为什么盘前买入成交,持仓不显示呢?","text":"$Innovate Biopharmaceuticals Inc.(INNT)$ 为什么盘前买入成交,持仓不显示呢?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/909587065","isVote":1,"tweetType":1,"viewCount":683,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909396611,"gmtCreate":1556110906233,"gmtModify":1704800013292,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$亚洲杂货(08413)$ 这破股总这么低价位,不会停牌破产吧","listText":"$亚洲杂货(08413)$ 这破股总这么低价位,不会停牌破产吧","text":"$亚洲杂货(08413)$ 这破股总这么低价位,不会停牌破产吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/909396611","isVote":1,"tweetType":1,"viewCount":2368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":900557423,"gmtCreate":1555679833462,"gmtModify":1704799440994,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Precipio, Inc.(PRPO)$ Preciio公司股份(PRPO)在周二的市场上涨,此前一天,该公司表示,将安排股东电话,审查为重新遵守纳斯达克每股1美元规则而采取的行动,以及该公司继续提高股价的计划。 下午3点49分。ET,专业癌症诊断公司的股票上涨了20.73%,以每股48美分的价格交易。成交量超过8,870万股,远高于65天平均成交量约630万股. Preciio表示,纳斯达克将其合规听证会定于5月2日举行.5月6日的股东电话会议将在该公司完成必要的行动后进行,这些行动旨在重新遵守纳斯达克上市要求。该交易所的股票必须有一个最低的1.00美元的出价,普雷西奥说。","listText":"$Precipio, Inc.(PRPO)$ Preciio公司股份(PRPO)在周二的市场上涨,此前一天,该公司表示,将安排股东电话,审查为重新遵守纳斯达克每股1美元规则而采取的行动,以及该公司继续提高股价的计划。 下午3点49分。ET,专业癌症诊断公司的股票上涨了20.73%,以每股48美分的价格交易。成交量超过8,870万股,远高于65天平均成交量约630万股. Preciio表示,纳斯达克将其合规听证会定于5月2日举行.5月6日的股东电话会议将在该公司完成必要的行动后进行,这些行动旨在重新遵守纳斯达克上市要求。该交易所的股票必须有一个最低的1.00美元的出价,普雷西奥说。","text":"$Precipio, Inc.(PRPO)$ Preciio公司股份(PRPO)在周二的市场上涨,此前一天,该公司表示,将安排股东电话,审查为重新遵守纳斯达克每股1美元规则而采取的行动,以及该公司继续提高股价的计划。 下午3点49分。ET,专业癌症诊断公司的股票上涨了20.73%,以每股48美分的价格交易。成交量超过8,870万股,远高于65天平均成交量约630万股. Preciio表示,纳斯达克将其合规听证会定于5月2日举行.5月6日的股东电话会议将在该公司完成必要的行动后进行,这些行动旨在重新遵守纳斯达克上市要求。该交易所的股票必须有一个最低的1.00美元的出价,普雷西奥说。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/900557423","isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":241274,"gmtCreate":1534172450622,"gmtModify":1704770128320,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Aytu BioScience, Inc.(AYTU)$今合股了,20股合1股,也不见涨呀","listText":"$Aytu BioScience, Inc.(AYTU)$今合股了,20股合1股,也不见涨呀","text":"$Aytu BioScience, Inc.(AYTU)$今合股了,20股合1股,也不见涨呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/241274","isVote":1,"tweetType":1,"viewCount":494,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":231026,"gmtCreate":1533013701192,"gmtModify":1704898325205,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$亚洲杂货(08413)$被骗进来巨亏,好在还在账上。福亿证券更缺德,把被骗深套的全给强平了,难友们欲哭无泪,预告无门,那是真惨呀!","listText":"$亚洲杂货(08413)$被骗进来巨亏,好在还在账上。福亿证券更缺德,把被骗深套的全给强平了,难友们欲哭无泪,预告无门,那是真惨呀!","text":"$亚洲杂货(08413)$被骗进来巨亏,好在还在账上。福亿证券更缺德,把被骗深套的全给强平了,难友们欲哭无泪,预告无门,那是真惨呀!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/231026","isVote":1,"tweetType":1,"viewCount":3280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":204311,"gmtCreate":1529072758714,"gmtModify":1704894946221,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$方舟生物医药(ABIO)$ 开盘拉高后跳水,诱多呀","listText":"$方舟生物医药(ABIO)$ 开盘拉高后跳水,诱多呀","text":"$方舟生物医药(ABIO)$ 开盘拉高后跳水,诱多呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/204311","isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":231026,"gmtCreate":1533013701192,"gmtModify":1704898325205,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$亚洲杂货(08413)$被骗进来巨亏,好在还在账上。福亿证券更缺德,把被骗深套的全给强平了,难友们欲哭无泪,预告无门,那是真惨呀!","listText":"$亚洲杂货(08413)$被骗进来巨亏,好在还在账上。福亿证券更缺德,把被骗深套的全给强平了,难友们欲哭无泪,预告无门,那是真惨呀!","text":"$亚洲杂货(08413)$被骗进来巨亏,好在还在账上。福亿证券更缺德,把被骗深套的全给强平了,难友们欲哭无泪,预告无门,那是真惨呀!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/231026","isVote":1,"tweetType":1,"viewCount":3280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":902143734,"gmtCreate":1559565610728,"gmtModify":1704698476201,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?","listText":"$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?","text":"$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/902143734","isVote":1,"tweetType":1,"viewCount":1115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":999432023,"gmtCreate":1563449785962,"gmtModify":1704705470343,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空","listText":"$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空","text":"$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空","images":[{"img":"https://static.tigerbbs.com/ebb3b6651e839cb360c74443aef2dc69"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/999432023","isVote":1,"tweetType":1,"viewCount":1618,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":999431035,"gmtCreate":1563448379627,"gmtModify":1704705466677,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。","listText":"$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。","text":"$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/999431035","isVote":1,"tweetType":1,"viewCount":2461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909524070,"gmtCreate":1556546999590,"gmtModify":1704800705123,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 创新生物制药股份有限公司(INNT)上涨45%,至2.76美元。 这家临床阶段生物技术公司周一表示,醋酸拉拉唑肽是第一种具有新机制的药物,其作用机制可用于证实非酒精性脂肪性肝炎(NASH)、生物标志物和终点的改善。该公司表示,醋酸拉拉嗪肽是一种新的药物,它是以肠限制肽为基础,将肠上皮屏障和肠-肝轴重新命名。 创新说,活检证实的纳什模型的关键图线发现将在消化疾病周会议的分析师会议上提出,并提交给美国肝病研究协会的肝脏会议。 这股今天有利好,走得这么磨叽,有点危呀,再看看吧","listText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 创新生物制药股份有限公司(INNT)上涨45%,至2.76美元。 这家临床阶段生物技术公司周一表示,醋酸拉拉唑肽是第一种具有新机制的药物,其作用机制可用于证实非酒精性脂肪性肝炎(NASH)、生物标志物和终点的改善。该公司表示,醋酸拉拉嗪肽是一种新的药物,它是以肠限制肽为基础,将肠上皮屏障和肠-肝轴重新命名。 创新说,活检证实的纳什模型的关键图线发现将在消化疾病周会议的分析师会议上提出,并提交给美国肝病研究协会的肝脏会议。 这股今天有利好,走得这么磨叽,有点危呀,再看看吧","text":"$Innovate Biopharmaceuticals Inc.(INNT)$ 创新生物制药股份有限公司(INNT)上涨45%,至2.76美元。 这家临床阶段生物技术公司周一表示,醋酸拉拉唑肽是第一种具有新机制的药物,其作用机制可用于证实非酒精性脂肪性肝炎(NASH)、生物标志物和终点的改善。该公司表示,醋酸拉拉嗪肽是一种新的药物,它是以肠限制肽为基础,将肠上皮屏障和肠-肝轴重新命名。 创新说,活检证实的纳什模型的关键图线发现将在消化疾病周会议的分析师会议上提出,并提交给美国肝病研究协会的肝脏会议。 这股今天有利好,走得这么磨叽,有点危呀,再看看吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/909524070","isVote":1,"tweetType":1,"viewCount":1131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909560768,"gmtCreate":1556543771954,"gmtModify":1704800687867,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 上车了就耐心持有,开盘再看","listText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 上车了就耐心持有,开盘再看","text":"$Innovate Biopharmaceuticals Inc.(INNT)$ 上车了就耐心持有,开盘再看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/909560768","isVote":1,"tweetType":1,"viewCount":1014,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909587065,"gmtCreate":1556543096157,"gmtModify":1704800685794,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 为什么盘前买入成交,持仓不显示呢?","listText":"$Innovate Biopharmaceuticals Inc.(INNT)$ 为什么盘前买入成交,持仓不显示呢?","text":"$Innovate Biopharmaceuticals Inc.(INNT)$ 为什么盘前买入成交,持仓不显示呢?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/909587065","isVote":1,"tweetType":1,"viewCount":683,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909396611,"gmtCreate":1556110906233,"gmtModify":1704800013292,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$亚洲杂货(08413)$ 这破股总这么低价位,不会停牌破产吧","listText":"$亚洲杂货(08413)$ 这破股总这么低价位,不会停牌破产吧","text":"$亚洲杂货(08413)$ 这破股总这么低价位,不会停牌破产吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/909396611","isVote":1,"tweetType":1,"viewCount":2368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":906433947,"gmtCreate":1559136165189,"gmtModify":1704697741892,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"title":"今天继续有利好","htmlText":"$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","listText":"$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","text":"$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 +148.17% 14.220 SOLITON INC (SOLY.US) 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/906433947","isVote":1,"tweetType":1,"viewCount":1529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":348750559,"gmtCreate":1617966706971,"gmtModify":1617966706971,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GURE\">$海湾资源(GURE)$</a>持仓4000股,怎么不显示,无法操作呀","listText":"<a href=\"https://laohu8.com/S/GURE\">$海湾资源(GURE)$</a>持仓4000股,怎么不显示,无法操作呀","text":"$海湾资源(GURE)$持仓4000股,怎么不显示,无法操作呀","images":[{"img":"https://static.tigerbbs.com/ff45161b606547954fd2876432f718a6","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/348750559","isVote":1,"tweetType":1,"viewCount":2810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":981217668,"gmtCreate":1583761156054,"gmtModify":1704350687354,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了","listText":"$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了","text":"$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/981217668","isVote":1,"tweetType":1,"viewCount":2402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":903912852,"gmtCreate":1556797891476,"gmtModify":1704801169213,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Hemispherx Biopharma Inc(HEB)$ 这股每天盘前诱多,套进多少人呀","listText":"$Hemispherx Biopharma Inc(HEB)$ 这股每天盘前诱多,套进多少人呀","text":"$Hemispherx Biopharma Inc(HEB)$ 这股每天盘前诱多,套进多少人呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/903912852","isVote":1,"tweetType":1,"viewCount":1062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":900557423,"gmtCreate":1555679833462,"gmtModify":1704799440994,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Precipio, Inc.(PRPO)$ Preciio公司股份(PRPO)在周二的市场上涨,此前一天,该公司表示,将安排股东电话,审查为重新遵守纳斯达克每股1美元规则而采取的行动,以及该公司继续提高股价的计划。 下午3点49分。ET,专业癌症诊断公司的股票上涨了20.73%,以每股48美分的价格交易。成交量超过8,870万股,远高于65天平均成交量约630万股. Preciio表示,纳斯达克将其合规听证会定于5月2日举行.5月6日的股东电话会议将在该公司完成必要的行动后进行,这些行动旨在重新遵守纳斯达克上市要求。该交易所的股票必须有一个最低的1.00美元的出价,普雷西奥说。","listText":"$Precipio, Inc.(PRPO)$ Preciio公司股份(PRPO)在周二的市场上涨,此前一天,该公司表示,将安排股东电话,审查为重新遵守纳斯达克每股1美元规则而采取的行动,以及该公司继续提高股价的计划。 下午3点49分。ET,专业癌症诊断公司的股票上涨了20.73%,以每股48美分的价格交易。成交量超过8,870万股,远高于65天平均成交量约630万股. Preciio表示,纳斯达克将其合规听证会定于5月2日举行.5月6日的股东电话会议将在该公司完成必要的行动后进行,这些行动旨在重新遵守纳斯达克上市要求。该交易所的股票必须有一个最低的1.00美元的出价,普雷西奥说。","text":"$Precipio, Inc.(PRPO)$ Preciio公司股份(PRPO)在周二的市场上涨,此前一天,该公司表示,将安排股东电话,审查为重新遵守纳斯达克每股1美元规则而采取的行动,以及该公司继续提高股价的计划。 下午3点49分。ET,专业癌症诊断公司的股票上涨了20.73%,以每股48美分的价格交易。成交量超过8,870万股,远高于65天平均成交量约630万股. Preciio表示,纳斯达克将其合规听证会定于5月2日举行.5月6日的股东电话会议将在该公司完成必要的行动后进行,这些行动旨在重新遵守纳斯达克上市要求。该交易所的股票必须有一个最低的1.00美元的出价,普雷西奥说。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/900557423","isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":999498730,"gmtCreate":1563443367720,"gmtModify":1704705456575,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Safe-T Group Ltd.(SFET)$先最多,高位在空","listText":"$Safe-T Group Ltd.(SFET)$先最多,高位在空","text":"$Safe-T Group Ltd.(SFET)$先最多,高位在空","images":[{"img":"https://static.tigerbbs.com/14e0898b30b721f21d10c17e189f69f8"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/999498730","isVote":1,"tweetType":1,"viewCount":1062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":906439220,"gmtCreate":1559136035760,"gmtModify":1704697741548,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","listText":"$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","text":"$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 +148.17% 14.220 SOLITON INC (SOLY.US) 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/906439220","isVote":1,"tweetType":1,"viewCount":1271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":241274,"gmtCreate":1534172450622,"gmtModify":1704770128320,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Aytu BioScience, Inc.(AYTU)$今合股了,20股合1股,也不见涨呀","listText":"$Aytu BioScience, Inc.(AYTU)$今合股了,20股合1股,也不见涨呀","text":"$Aytu BioScience, Inc.(AYTU)$今合股了,20股合1股,也不见涨呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/241274","isVote":1,"tweetType":1,"viewCount":494,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":958719449,"gmtCreate":1591365437981,"gmtModify":1704195558630,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"这是过山车吗?跌停、涨停,再跌停,在涨停,。。。","listText":"这是过山车吗?跌停、涨停,再跌停,在涨停,。。。","text":"这是过山车吗?跌停、涨停,再跌停,在涨停,。。。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/958719449","isVote":1,"tweetType":1,"viewCount":1186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":902963026,"gmtCreate":1559305500065,"gmtModify":1704698177750,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注","listText":"$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注","text":"$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/902963026","isVote":1,"tweetType":1,"viewCount":1102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":906315261,"gmtCreate":1558616498653,"gmtModify":1704696993633,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Obalon Therapeutics Inc(OBLN)$ 开牌就暴跌呀","listText":"$Obalon Therapeutics Inc(OBLN)$ 开牌就暴跌呀","text":"$Obalon Therapeutics Inc(OBLN)$ 开牌就暴跌呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/906315261","isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":204311,"gmtCreate":1529072758714,"gmtModify":1704894946221,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$方舟生物医药(ABIO)$ 开盘拉高后跳水,诱多呀","listText":"$方舟生物医药(ABIO)$ 开盘拉高后跳水,诱多呀","text":"$方舟生物医药(ABIO)$ 开盘拉高后跳水,诱多呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/204311","isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}